\BOOKMARK [0][-]{chapter*.5}{List of Figures}{}% 1
\BOOKMARK [0][-]{chapter*.6}{List of Tables}{}% 2
\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 3
\BOOKMARK [1][-]{section.1.1}{Alzheimer's Disease}{chapter.1}% 4
\BOOKMARK [1][-]{section.1.2}{Posterior Cortical Atrophy}{chapter.1}% 5
\BOOKMARK [1][-]{section.1.3}{Disease Progression Models}{chapter.1}% 6
\BOOKMARK [1][-]{section.1.4}{Problem Statement}{chapter.1}% 7
\BOOKMARK [1][-]{section.1.5}{Justification}{chapter.1}% 8
\BOOKMARK [1][-]{section.1.6}{Thesis Contributions}{chapter.1}% 9
\BOOKMARK [1][-]{section.1.7}{Thesis Structure}{chapter.1}% 10
\BOOKMARK [0][-]{chapter.2}{Background \205 Alzheimer's Disease}{}% 11
\BOOKMARK [1][-]{section.2.1}{Alzheimer's Disease}{chapter.2}% 12
\BOOKMARK [1][-]{section.2.2}{Progression of Alzheimer's Disease}{chapter.2}% 13
\BOOKMARK [1][-]{section.2.3}{Posterior Cortical Atrophy}{chapter.2}% 14
\BOOKMARK [0][-]{chapter.3}{Background \205 Disease Progression Models}{}% 15
\BOOKMARK [1][-]{section.3.1}{Hypothetical Models}{chapter.3}% 16
\BOOKMARK [1][-]{section.3.2}{Models of Progression using Symptomatic Groups}{chapter.3}% 17
\BOOKMARK [1][-]{section.3.3}{Regression Against One Biomarker}{chapter.3}% 18
\BOOKMARK [1][-]{section.3.4}{Survival Analysis Models}{chapter.3}% 19
\BOOKMARK [1][-]{section.3.5}{Scalar Biomarker Models}{chapter.3}% 20
\BOOKMARK [1][-]{section.3.6}{Spatiotemporal Disease Progression Models}{chapter.3}% 21
\BOOKMARK [1][-]{section.3.7}{Mechanistic Models}{chapter.3}% 22
\BOOKMARK [1][-]{section.3.8}{Machine Learning Methods}{chapter.3}% 23
\BOOKMARK [1][-]{section.3.9}{Summary}{chapter.3}% 24
\BOOKMARK [0][-]{chapter.4}{Longitudinal Neuroanatomical Progression of PCA}{}% 25
\BOOKMARK [1][-]{section.4.1}{Publications}{chapter.4}% 26
\BOOKMARK [1][-]{section.4.2}{Introduction}{chapter.4}% 27
\BOOKMARK [1][-]{section.4.3}{Methods}{chapter.4}% 28
\BOOKMARK [1][-]{section.4.4}{Results}{chapter.4}% 29
\BOOKMARK [1][-]{section.4.5}{Discussion}{chapter.4}% 30
\BOOKMARK [1][-]{section.4.6}{Conclusion}{chapter.4}% 31
\BOOKMARK [0][-]{chapter.5}{Novel Extensions to the EBM and DEM}{}% 32
\BOOKMARK [1][-]{section.5.1}{Contributions}{chapter.5}% 33
\BOOKMARK [1][-]{section.5.2}{Introduction}{chapter.5}% 34
\BOOKMARK [1][-]{section.5.3}{Methods}{chapter.5}% 35
\BOOKMARK [1][-]{section.5.4}{Results}{chapter.5}% 36
\BOOKMARK [1][-]{section.5.5}{Discussion}{chapter.5}% 37
\BOOKMARK [1][-]{section.5.6}{Summary}{chapter.5}% 38
\BOOKMARK [1][-]{section.5.7}{Conclusion}{chapter.5}% 39
\BOOKMARK [0][-]{chapter.6}{DIVE: A Spatiotemporal Progression Model of Brain Pathology}{}% 40
\BOOKMARK [1][-]{section.6.1}{Publications}{chapter.6}% 41
\BOOKMARK [1][-]{section.6.2}{Introduction}{chapter.6}% 42
\BOOKMARK [1][-]{section.6.3}{Methods}{chapter.6}% 43
\BOOKMARK [1][-]{section.6.4}{Results}{chapter.6}% 44
\BOOKMARK [1][-]{section.6.5}{Discussion}{chapter.6}% 45
\BOOKMARK [1][-]{section.6.6}{Conclusion}{chapter.6}% 46
\BOOKMARK [0][-]{chapter.7}{Disease Knowledge Transfer across Neurodegenerative Diseases}{}% 47
\BOOKMARK [1][-]{section.7.1}{Contributions}{chapter.7}% 48
\BOOKMARK [1][-]{section.7.2}{Publications}{chapter.7}% 49
\BOOKMARK [1][-]{section.7.3}{Introduction}{chapter.7}% 50
\BOOKMARK [1][-]{section.7.4}{Methods}{chapter.7}% 51
\BOOKMARK [1][-]{section.7.5}{Results}{chapter.7}% 52
\BOOKMARK [1][-]{section.7.6}{Validation on DTI Data in PCA}{chapter.7}% 53
\BOOKMARK [1][-]{section.7.7}{Discussion}{chapter.7}% 54
\BOOKMARK [1][-]{section.7.8}{Conclusion}{chapter.7}% 55
\BOOKMARK [0][-]{chapter.8}{TADPOLE Challenge: Prediction of Evolution in Alzheimer's Disease}{}% 56
\BOOKMARK [1][-]{section.8.1}{Contributions}{chapter.8}% 57
\BOOKMARK [1][-]{section.8.2}{Publications}{chapter.8}% 58
\BOOKMARK [1][-]{section.8.3}{Introduction}{chapter.8}% 59
\BOOKMARK [1][-]{section.8.4}{Competition Design}{chapter.8}% 60
\BOOKMARK [1][-]{section.8.5}{Forecasts}{chapter.8}% 61
\BOOKMARK [1][-]{section.8.6}{Data}{chapter.8}% 62
\BOOKMARK [1][-]{section.8.7}{TADPOLE Datasets}{chapter.8}% 63
\BOOKMARK [1][-]{section.8.8}{Submissions}{chapter.8}% 64
\BOOKMARK [1][-]{section.8.9}{Forecast Evaluation}{chapter.8}% 65
\BOOKMARK [1][-]{section.8.10}{Prizes}{chapter.8}% 66
\BOOKMARK [1][-]{section.8.11}{Discussion}{chapter.8}% 67
\BOOKMARK [1][-]{section.8.12}{Conclusion}{chapter.8}% 68
\BOOKMARK [0][-]{chapter.9}{Conclusions}{}% 69
\BOOKMARK [1][-]{section.9.1}{Summary}{chapter.9}% 70
\BOOKMARK [1][-]{section.9.2}{Future Research Directions}{chapter.9}% 71
\BOOKMARK [0][-]{appendix.A}{Longitudinal Neuroanatomical Progression of PCA}{}% 72
\BOOKMARK [0][-]{appendix.B}{DIVE: A Spatiotemporal Progression Model of Brain Pathology}{}% 73
\BOOKMARK [1][-]{section.B.1}{Simulations - Error in Estimated Trajectories and DPS}{appendix.B}% 74
\BOOKMARK [1][-]{section.B.2}{Comparison Between DIVE and Other Models}{appendix.B}% 75
\BOOKMARK [1][-]{section.B.3}{Derivation of the Generalised EM Algorithm}{appendix.B}% 76
\BOOKMARK [1][-]{section.B.4}{Fast DIVE Implementation - Proof of Equivalence}{appendix.B}% 77
\BOOKMARK [0][-]{appendix.C}{Disease Knowledge Transfer across Neurodegenerative Diseases}{}% 78
\BOOKMARK [0][-]{appendix.D}{Novel Extensions to the EBM and DEM}{}% 79
\BOOKMARK [1][-]{section.D.1}{EBM Fitting using Expectation-Maximisation}{appendix.D}% 80
\BOOKMARK [0][-]{appendix.E}{TADPOLE Challenge: Prediction of Longitudinal Evolution in AD}{}% 81
\BOOKMARK [1][-]{section.E.1}{Expected Number of Subjects and Available Data for D4}{appendix.E}% 82
\BOOKMARK [0][-]{appendix.F}{Bibliography}{}% 83
